Adverse Drug Reaction News Bulletins
ADR News Bulletin 2024 December (Volume 26 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
30 December 2024
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Potential risk of psychiatric withdrawal events with domperidone for stimulation of lactation
Overview of serious adverse event reports associated with programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitors
Biosimilars evaluation: Update on HSA’s regulatory considerations for clinical comparability studies
AE Case in Focus: Test Yourself - What could have contributed to the patient's euglycaemic diabetic ketoacidosis (eDKA)?
Click on the link below to download the issue in pdf: